Short-term repeated-dose toxicity profile of archaeosomes administered to mice via intravenous and oral routes

International Journal of Toxicology

Volumn 22, Issue 1, 2003, Pages 9-23

  Omri, Abdelwahab ^a,b   Agnew, Brian J ^b   Patel, Girishchandra B ^b  

^a LAURENTIAN UNIVERSITY   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Archaeosomes; Ether Lipids; Liposomes; Toxicity

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DIMYRISTOYLPHOSPHATIDYLGLYCEROL; ETHER LIPID; LIPOSOME; PHOSPHATE; PHOSPHOLIPID; SODIUM CHLORIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; COLORIMETRY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HALOBACTERIUM SALINARUM; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NATRONOBACTERIUM; NONHUMAN; ORAL DRUG ADMINISTRATION; REFLEX; SPLENOMEGALY; TOXICITY; WEIGHT REDUCTION;

ADMINISTRATION, ORAL; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMALS; ARCHAEA; ASPARTATE AMINOTRANSFERASES; BLOOD GLUCOSE; BLOOD UREA NITROGEN; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART; INJECTIONS, INTRAVENOUS; KIDNEY; LIPIDS; LIPOSOMES; LIVER; LUNG; MICE; MICE, INBRED BALB C; ORGAN SIZE; TEMPERATURE; TIME FACTORS;

ANIMALIA; ARCHAEA; HALOBACTERIUM SALINARUM; HALOPHILIC ARCHAEON; NATRIALBA MAGADII; NATRONOBACTERIUM;

EID: 0037231657     PISSN: 10915818     EISSN: None     Source Type: Journal    
DOI: 10.1080/10915810305080     Document Type: Article

References (38)

1. Allen, T. M. 1993. Toxicity and systemic effects of phospholipids. In Phospholipids handbook, ed. G. Cevc, 801-816. New York: Marcel Dekker.
2. Allen, T. M., L. Murray, S. MacKeigan, and M. Shah. 1984. Chronic liposome administration in mice: Effects on reticuloendothelial function and tissue distribution. J. Pharmacol. Exp. Ther. 229:267-275.
3. Allen, T. M., and E. A. Smuckler. 1985. Liver pathology accompanying chronic liposome administration in mouse. Res. Commun. Chem. Pathol. Pharmacol. 50:282-290.
4. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917.
5. Brusa, T., E. Canzi, L. Allieve, E. Del Puppo, and A. Ferrari. 1993. Methanogens in the human intestinal tract and oral cavity. Curr. Microbiol. 27:261-265.
6. Campbell, P. I. 1983. Toxicity of some charged lipids used in liposome preparations. Cytobios 37:21-26.
7. Choquet, C. G., G. B. Patel, T. J. Beveridge, and G. D. Sprott. 1994. Stability of pressure-extruded liposomes made from archaeobacterial ether lipids. Appl. Microbiol. Biotechnol. 42:375-384.
8. Claassen, E., Y. Westerhof, B. Versluis, N. Kors, M. Schellekens, and N. van Rooijen. 1988. Effects of chronic injection of sphingomyelin-containing liposomes on lymphoid and non-lymphoid cells in the spleen. Transient suppression of marginal zone macrophages. Br. J. Exp. Pathol. 69:865-875.
9. Derksen, J. T. P., J. D. Baldeschwieler, and G. L. Scherphof. 1988. In vivo stability of ester- and ether-linked phospholipid-containing liposomes as measured by perturbed angular correlation spectroscopy. Proc. Natl. Acad. Sci. U.S.A. 85:9768-9772.
10. Deshmukh, D. S., W. D. Bear, H. M. Wisniewski, and H. Brockerhoff. 1978. Long-living liposomes as potential drug carriers. Biochem. Biophys. Res. Commun. 82:328-334.
11. Freisleben, H.-J., J. Bormann, D. C. Litzinger, F. Lehr, P. Rudolph, W. Schatton, and L. Huang. 1995. Toxicity and biodistribution of liposomes of the main phospholipid from the archaeobacterium Thermoplasma acidophilum in mice. J. Liposome Res. 5:215-223.
12. Freisleben, H.-J., C. Neisser, M. Hartmann, P. Rudolph, P. Geck, K. Ring, and E. G. Müller. 1993. Influence of the main phospholipid (MPL) from Thermoplasma acidophilum and of liposomes from MPL on living cells: Cytotoxicity and mutagenicity. J. Liposome Res. 3:817-833.
13. Hrčková, G., A. Shah, D. T. Hart, and D. W. Halton. 1994. A comparative study of the utilization of ether- and ester-linked phospholipid-containing liposomes by J774.E1 macrophage cell-line infected with Leishmania mexicana mexicana amastigotes. Folia Parasitol. 14:161-167.
14. Jonah, M. N., E. A. Cerny, and Y. E. Rahman. 1975. Tissue distribution of EDTA encapsulated within liposomes of varying surface properties. Biochim. Biophys. Acta 401:336-348.
15. Kandler, O., and H. Konig. 1985. Cell envelopes of archaebacteria. In The Bacteria, vol. VIII, eds. C. R. Woese and R. S. Wolfe, 413-457. New York: Academic Press.
16. Kates, M. 1993. Archaebacterial lipids: Structure, biosynthesis and function. Biochem. Soc. Symp. 58:51-72.
17. Kates, M. 1997. Diether and tetraether phospholipids and glycolipids as molecular markers for Archaebacteria (Archaea). Am. Chem. Soc. Symp. Ser. 671:35-47.
18. Krieg, N. R. 2001. Procaryotic domains. In Bergey's manual of systematic bacteriology, 2nd ed., vol. 1, eds. D. R. Boone and R. W. Castenholz, 21-25. New York: Springer-Verlag.
19. + help. J. Immunol. 165:5177-5185.
20. Mayhew, E., M. Ito, and R. Lazo. 1987. Toxicity of non-drug containing liposomes for cultured human cells. Exp. Cell Res. 171:195-202.
21. Miller, T. L., and M. J. Wolin. 1986. Methanogens in human and animal intestinal tracts. System. Appl. Microbiol. 7:223-229.
22. Omri, A., B. Makabi-Panzu, B. J. Agnew, G. D. Sprott, and G. B. Patel. 2000. Influence of coenzyme Q10 on tissue distribution of archaeosomes, and pegylated archaeosomes, administered to mice by oral and intravenous routes. J. Drug Targeting 7:383-392.
23. Parnham, M. J., and H. Wetzig. 1993. Toxicity screening of liposomes. Chem. Phys. Lipids 64:263-274.
24. Patel, G. B., B. J. Agnew, L. Deschatelets, L. P. Fleming, and G. D. Sprott. 2000. In vitro assessment of archaeosome stability for developing oral delivery systems. Int. J. Pharm. 194:39-49.
25. Patel, G. B., and G. D. Sprott. 1999. Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems. Crit. Rev. Biotechnol. 19:317-357.
26. Preece, A. 1972. A manual for histologic technicians, 3rd ed. Boston: Little, Brown and Company.
27. Rogers, J. A., and K. E. Anderson. 1998. The potential of liposomes in oral drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 15:421-480.
28. Snyder, F. 1991. Metabolism, regulation, and function of ether-linked glycerolipids and their bioactive species. In Biochemistry of lipids, lipoproteins and membranes, eds. D. E. Vance and J. Vance, 241-267. Amsterdam: Elsevier Science Publishers B. V.
29. Sprott, G. D. 1992. Structures of archaeobacterial membrane lipids. J. Bioenerg. Biomembr. 24:555-566.
30. Sprott, G. D., C. G. Choquet, and G. B. Patel. 1995. Purification of ether lipids and liposome formation from polar lipid extracts of methanogenic archaea. In Methanogens. Archaea - a laboratory manual, eds. K. R. Sowers and H. R. Schreier, 329-340. Plainview, NY: Cold Spring Harbor Laboratory Press.
31. Sprott, G. D., L. Krishnan, J. W. Conlan, A. Omri, and G. B. Patel. 2001. Archaeosomes as immunomodulating carriers for acellular vaccines to induce cytotoxic T lymphocyte (CTL) responses and protect the vaccinated host against intracellular pathogens and cancer. PCT International publication no. WO 01/26683; 19 April 2001. World Intellectual Property Organization, Geneva, Switzerland.
32. Sprott, G. D., D. L. Tolson, and G. B. Patel. 1997. Archaeosomes as novel antigen delivery systems. FEMS Microbiol. Lett. 154:17-22.
33. Stensrud, G., J. Monkkonen, and J. Karlsen. 1999. Toxicity of gamma irradiated liposomes. 2. In vitro effects on cells in culture. Int. J. Pharm. 178:47-53.
34. Storm, G., C. Oussoren, P. A. M. Peeters, and Y. Barenholz. 1993. Tolerability of liposomes in vivo. In Liposome technology, 2nd ed. Vol. 3, Interaction of liposomes with the biological milieu, ed. G. Gregoriadis, 345-383. Boca Raton, FL: CRC Press.
35. Tolson, D. L., R. K. Latta, G. B. Patel, and G. D. Sprott. 1996. Uptake of archaeobacterial liposomes and conventional liposomes by phagocytic cells. J. Liposome Res. 64:755-776.
36. Weereratne, E. A. H., G. Gregoriadis, and J. Crow. 1983. Toxicity of sphingomyelin-containing liposomes after chronic injection in mice. Br J. Exp. Pathol. 64:670-676.
37. Weiner, A. L., J. B. Cannon, and P. Tyle. 1989. Commercial approaches to the delivery of macromolecular drugs with liposomes. In Controlled release of drugs: Polymers and aggregate systems, ed. M. Rosoff, 217-252. New York: VCH Publishers.
38. Woodley, J. F. 1984. Liposomes for oral administration of drugs. CRC Crit. Rev. Ther. Drug Carrier Syst. 2:2-18.